Company Filing History:
Years Active: 1995
Title: Laura E Fredenburgh: Innovator in Pharmaceutical Chemistry
Introduction
Laura E Fredenburgh is a notable inventor based in Bayonne, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of key compounds used in medical treatments. Her work has implications for the development of Angiotensin II receptor antagonists, which are important in managing various cardiovascular conditions.
Latest Patents
Laura holds a patent for a process related to the preparation of imidazolutidine. This invention outlines a method for synthesizing a compound that serves as a crucial intermediate in the production of Angiotensin II receptor antagonists. The patent also describes a selective reagent for conducting the Hofmann rearrangement, which is essential in forming pyridinoimidazolone. This compound is a precursor to the formation of imidazopyridine, further emphasizing the importance of her work in pharmaceutical applications.
Career Highlights
Laura is currently employed at Merck & Company, Inc., a leading global healthcare company. Her role involves research and development in the pharmaceutical sector, where she applies her expertise in chemistry to innovate new therapeutic solutions. Her contributions have been instrumental in advancing the company's research initiatives.
Collaborations
Throughout her career, Laura has collaborated with esteemed colleagues, including Robert D Larsen and Ji Liu. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the field.
Conclusion
Laura E Fredenburgh exemplifies the impact of innovative thinking in pharmaceutical chemistry. Her patent work and collaborations highlight her commitment to advancing medical science and improving patient outcomes. Her contributions continue to shape the future of drug development.